For Manuscript Submission, Check or Review Login please go to Submission Websites List.
For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.
Late Development of Diabetes mellitus after Interferon-Alfa and Ribavirin Therapy for Chronic Hepatitis C: A Case ReportRadhakrishnan S.a · Upadhyay A.a · Mohan N.a · Dhar A.a · Walia H.a · Zubaidi G.b
Departments of aGastroenterology and bEndocrinology, The Royal Hospital, Muscat, Oman Corresponding Author
Dr. S. Radhakrishnan, FRCP (Edin)
The Royal Hospital, PO Box 1331, CPO 111
Tel./Fax +968 594461, E-Mail email@example.com
Objective: To report the late development of immune-mediated diabetes mellitus after completion of alfa-interferon therapy for hepatitis C in an Asian patient. Clinical Presentation and Intervention: A 50-year-old male with chronic hepatitis C received treatment with alfa-interferon and ribavirin for 52 weeks. He developed immune-mediated diabetes mellitus with low C-peptide and positive antiglutamic acid decarboxylase antibody after completion of therapy. The hepatitis C infection was eradicated, but he continued to be diabetic requiring insulin therapy during the follow-up. Conclusion: This report shows thatimmune-mediateddiabetes mellitus can occur as a late complication of alfa-interferon therapy.
© 2005 S. Karger AG, Basel